Cargando…

Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamases (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH)

BACKGROUND: Ertapenem (preferred choice for ESBL-producing organisms) use exhibited an increasing trend from 2006 to 2008. As extensive use of ertapenem might induce the mutation of resistant bacteria strains to ertapenem, we aimed to assess the appropriateness and impact of ertapenem-use, on ESBL p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Cheryl Li-Ling, Lee, Winnie, Lee, Amanda Ling-Chiu, Liew, Lisa Ting-Ting, Nah, Szu Chin, Wan, Choon Nam, Chlebicki, Maciej Piotr, Kwa, Andrea Lay-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879226/ https://www.ncbi.nlm.nih.gov/pubmed/24195651 http://dx.doi.org/10.1186/1471-2334-13-523

Ejemplares similares

34. Stemming the Rise in Antibiotic Prescription for Community Acquired Respiratory Infections (ARI) During COVID-19 Pandemic in Singapore General Hospital (SGH)
por: Lim, Shena Yun Chun, et al.
Publicado: (2021)

Impact of Antimicrobial Stewardship Program (ASP) on Outcomes in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in an Acute-Tertiary Care Hospital
por: Loo, Li Wen, et al.
Publicado: (2015)

Risk Factors, Molecular Epidemiology and Outcomes of Ertapenem-Resistant, Carbapenem-Susceptible Enterobacteriaceae: A Case-Case-Control Study
por: Teo, Jocelyn, et al.
Publicado: (2012)

Ertapenem for multiple β-lactamases producing Gram-negative bacteria causing urinary tract infections in HIV patients
por: Kumar, Marimuthu Ragavan Ramesh, et al.
Publicado: (2017)

Cloning, expression, purification and crystallization of a pair of novel virulence factors, SghA and SghR, from Agrobacterium tumefaciens
por: Ye, Fuzhou, et al.
Publicado: (2015)

Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms
por: Mody, Rupal M, et al.
Publicado: (2007)

Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution
por: Liew, Yi Xin, et al.
Publicado: (2015)

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study
por: Ortiz-Álvarez, Arturo, et al.
Publicado: (2018)

An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal Sepsis
por: Lee, Winnie, et al.
Publicado: (2014)

Extended Spectrum Beta-Lactamase (ESBL) Produced by Gram-Negative Bacteria in Trinidad and Tobago
por: Akpaka, Patrick Eberechi, et al.
Publicado: (2021)

Nonattenuated Polymyxin B Used for the Treatment of Extreme-Drug Resistant Acinetobacter baumannii-Related Infections in Patients with Preexisting End Stage Renal Failure
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014)

From Penicillin-Streptomycin to Amikacin-Vancomycin: Antibiotic Decontamination of Cardiovascular Homografts in Singapore
por: Heng, Wee Ling, et al.
Publicado: (2012)

1079. Impact of Antimicrobial Stewardship Program (ASP) on Patients with Neurological Conditions
por: Hoon Andrea Kwa, Lay, et al.
Publicado: (2019)

Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study
por: Cai, Yiying, et al.
Publicado: (2020)

213 Impact of Antimicrobial Stewardship Strategies on Antimicrobial Use: A Systematic Review
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014)

Development and Validation of an Haemophilus influenzae Supragenome Hybridization (SGH) Array for Transcriptomic Analyses
por: Janto, Benjamin A., et al.
Publicado: (2014)

The Clinical Efficacy and Safety of Ertapenem for the Treatment of Complicated Urinary Tract Infections Caused by ESBL-Producing Bacteria in Children
por: Karaaslan, Ayse, et al.
Publicado: (2015)

Detection of Beta-Lactamases (ESBL and MBL) Producing Gram-Negative Pathogens in National Public Health Laboratory of Nepal
por: Shrestha, Anjana, et al.
Publicado: (2022)

Acute decompensated heart failure in a non cardiology tertiary referral centre, Sarawak General Hospital (SGH-HF)
por: Ling, Hwei Sung, et al.
Publicado: (2020)

Add-On Therapy with Ertapenem in Infections with Multidrug Resistant Gram-Negative Bacteria: Pediatric Experience
por: Tanır Basaranoglu, Sevgen, et al.
Publicado: (2017)

713 Short vs Long Courses of Antibiotic Treatment in Adults with Uncomplicated Gram-negative Bacteremia in a Tertiary Inistituition
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014)

Phenotypic detection of Extended Spectrum β-Lactamases (ESBL) among gram negative uropathogens reveals highly susceptibility to imipenem
por: Mohammed, Isra, et al.
Publicado: (2019)

Ertapenem-Induced Thrombocytosis
por: Docobo, Ramon A, et al.
Publicado: (2017)

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
por: Husna, Asmaul, et al.
Publicado: (2023)

Prevalence and acquisition rate of extended spectrum beta lactamase producing gram-negative organisms (ESBL-GNO) in general medical patients in Switzerland
por: Pasricha, J, et al.
Publicado: (2011)

Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: A meta-analysis report in Ethiopia
por: Abayneh, Mengistu, et al.
Publicado: (2020)

477. Characterization of Extended-Spectrum Β-Lactamase (ESBL) Producing Gram-negative (GN) Urinary Tract Infections (UTI) in Pediatric Patients
por: Stach, Leslie, et al.
Publicado: (2019)

EVALUATION OF PHENOTYPIC AND MOLECULAR TECHNIQUE IN THE DETECTION OF EXTENDED SPECTRUM BETA-LACTAMASE (ESBL)-PRODUCING GRAM NEGATIVE BACILLI IN OGUN STATE, NIGERIA
por: Ajani, T.A., et al.
Publicado: (2022)

Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
por: Lee, Chen-Hsiang, et al.
Publicado: (2018)

Ertapenem Resistance of Escherichia coli
por: Lartigue, Marie-Frédérique, et al.
Publicado: (2007)

Extended-Spectrum β-Lactamases (ESBL) Producing Bacteria in Animals
por: Tseng, Chien-Hao, et al.
Publicado: (2023)

Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers
por: Singh, Bhoj R
Publicado: (2018)

Analysis of Extended Spectrum Beta Lactamase (ESBL) Genes of Non-Invasive ESBL Enterobacterales in Southeast Austria in 2017
por: Paulitsch-Fuchs, Astrid H., et al.
Publicado: (2022)

Long-Lasting Decrease of the Acquisition of Enterococcus faecium and Gram-Negative Bacteria Producing Extended Spectrum Beta-Lactamase (ESBL) by Transient Application of Probiotics
por: Borgmann, Stefan, et al.
Publicado: (2020)

Non-catalytic-Region Mutations Conferring Transition of Class A β-Lactamases Into ESBLs
por: Cao, Thinh-Phat, et al.
Publicado: (2020)

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli
por: Seo, Yu Bin, et al.
Publicado: (2017)

Prevalence of invasive fungal disease in hematological patients at a tertiary university hospital in Singapore
por: Lee, Siok-Ying, et al.
Publicado: (2011)

Colonization sites in carriers of ESBL-producing Gram-negative bacteria
por: van Prehn, Joffrey, et al.
Publicado: (2018)

Distribution of Extended-Spectrum β-Lactamase (ESBL)-Encoding Genes among Multidrug-Resistant Gram-Negative Pathogens Collected from Three Different Countries
por: Azab, Khaled S. M., et al.
Publicado: (2021)

Ertapenem rescue therapy in hidradenitis suppurativa
por: Chahine, Adam A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6pn323kvnuibeo5b72dhveho40